It was found that MCF-7-derived cancer stem cells (CSCs) with a CD44high/CD24low phenotype formed mammospheres and highly expressed NRF2 and exhibited less sensitivity to paclitaxel compared to adherent parental breast cancer MCF-7 cells [69]. This evidence concerns the gene NFE2L2 and breast cancer.